The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The Metalloprotease Disintegrin ADAM8
Open accessAbstract
ADAMs (a disintegrin and metalloprotease domains) are metalloprotease and disintegrin domain-containing transmembrane glycoproteins with proteolytic, cell adhesion, cell fusion, and cell signaling properties. ADAM8 was originally cloned from monocytic cells, and its distinct expression pattern indicates possible roles in both immunology and neuropathology. Here we describe our analysis of its biochemical properties. In transfected COS-7 cells, ADAM8 is localized to the plasma membrane and processed into two forms derived either by prodomain removal or as remnant protein comprising the extracellular region with the disintegrin domain at the N terminus. Proteolytic removal of the ADAM8 propeptide was completely blocked in mutant ADAM8 with a Glu(330) to Gln exchange (EQ-A8) in the Zn(2+) binding motif (HE(330)LGHNLGMSHD), arguing for autocatalytic prodomain removal. In co-transfection experiments, the ectodomain but not the entire MP domain of ADAM8 was able to remove the prodomain from EQ-ADAM8. With cells expressing ADAM8, cell adhesion to a substrate-bound recombinant ADAM8 disintegrin/Cys-rich domain was observed in the absence of serum, blocked by an antibody directed against the ADAM8 disintegrin domain. Soluble ADAM8 protease, consisting of either the metalloprotease domain or the complete ectodomain, cleaved myelin basic protein and a fluorogenic peptide substrate, and was inhibited by batimastat (BB-94, IC(50) approximately 50 nm) but not by recombinant tissue inhibitor of matrix metalloproteinases 1, 2, 3, and 4. Our findings demonstrate that ADAM8 processing by autocatalysis leads to a potential sheddase and to a form of ADAM8 with a function in cell adhesion.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, loss of its proteolytic activity is predicted in eutherians 42 owing to a single point mutation within its active site (E to Q).”
From Genome analysis of the platypus reveals unique signatures of evolution (2008) · cites this paper as [42]
Citations
Cites
A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
An Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,622
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α
Moss, M. L., Jin, S.-L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W.-J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., et al. (1997) · Nature · doi:10.1038/385733a0 · Cited by 1,378
Self-citationA Novel Proteolytic Cleavage Involved in Notch Signaling
Brou, C., Logeat, F., Gupta-Rossi, N., Chable-Bessia, C., Bail, O. L., Doedens, J. R., Cumano, A., Roux, P., Black, R. A., & Israël, A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80417-7 · Cited by 1,115
Lammich, S., Kojro, E., Postina, R., Gilbert, S., Pfeiffer, R., Jasionowski, M., Haass, C., & Fahrenholz, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3922 · Cited by 975
Buxbaum, J. D., Liu, K.-N., Luo, Y., Slack, J. L., Stocking, K. L., Peschon, J. J., Johnson, R. S., Castner, B. J., Cerretti, D. P., & Black, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.27765 · Cited by 952
TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3
Amour, A., Slocombe, P. M., Webster, A., Butler, M., Knight, C. G., Smith, B. J., Stephens, P. E., Shelley, C., Hutton, M., Knäuper, V., et al. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01031-x · Cited by 609
Self-citationThe ADAM gene family: surface proteins with adhesion and protease activity
Primakoff, P., & Myles, D. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01926-5 · Cited by 582
Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., Tamai, Y., Kurisaki, T., Sehara‐Fujisawa, A., Ohno, S., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7260 · Cited by 526
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–173 of 173
ADAM8 in Asthma. Friend or Foe to Airway Inflammation?
Chen, J., Jiang, X., Duan, Y., Long, J., Bartsch, J. W., & Deng, L. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0168tr · Cited by 21
Self-citationProtective effects of ADAM8 against cisplatin‐mediated apoptosis in non‐small‐cell lung cancer
Zhang, W., Wan, M., Ma, L., Liu, X., & He, J. (2012) · Cell Biology International · doi:10.1002/cbin.10011 · Cited by 22
Ma, H., Qin, S., & Zhao, S. (2020) · Medical Science Monitor · doi:10.12659/msm.921276 · Cited by 21
High ADAM8 Expression is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma
Zhang, Y., Tan, Y., Jiang, C., Zhang, K., Zha, T.-Z., & Zhang, M. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-012-9560-6 · Cited by 19
Yang, H., & Khalil, R. A. (2022) · Advances in pharmacology · doi:10.1016/bs.apha.2021.11.002 · Cited by 18
Deficiency of the Metalloproteinase-Disintegrin ADAM8 Is Associated with Thymic Hyper-Cellularity
Gossens, K., Naus, S., Holländer, G. A., & Ziltener, H. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012766 · Cited by 17
Yim, V. V., Noisier, A. F. M., Hung, K., Bartsch, J. W., Schlomann, U., & Brimble, M. A. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.06.042 · Cited by 17
Self-citationSchick, D., Babendreyer, A., Wozniak, J., Awan, T., Noels, H., Liehn, E. A., Bartsch, J. W., Vlacil, A.-K., Grote, K., Zayat, R., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.03.008 · Cited by 17
Self-citationsiRNA-Mediated Timp1 Silencing Inhibited the Inflammatory Phenotype during Acute Lung Injury
Chernikov, I. V., Staroseletz, Y., Tatarnikova, I. S., Васильевна, С. А., Savin, I. A., Markov, A. V., Logashenko, E. B., Chernolovskaya, E. L., Аркадьевна, З. М., & Vlassov, V. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021641 · Cited by 16
Gibson, S. V., Madzharova, E., Tan, A. C., Allen, M. D., Keller, U. A. D., Jones, J. L., Carter, E. P., & Grose, R. P. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.06.005 · Cited by 16
Structure of human ADAM-8 catalytic domain complexed with batimastat
Hall, T., Shieh, H., Day, J. E., Caspers, N. L., Chrencik, J., Williams, J. M., Pegg, L. E., Pauley, A. M., Moon, A. F., Krahn, J. M., et al. (2012) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309112015618 · Cited by 19
Sharma, D., & Singh, N. K. (2021) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2021_67 · Cited by 16
A jack of all trades – ADAM8 as a signaling hub in inflammation and cancer
Cook, L., Gharzia, F. G., Bartsch, J. W., & Yildiz, D. (2023) · FEBS Journal · doi:10.1111/febs.17034 · Cited by 13
Self-citationRegulating inflammation: ADAM8 – a new player in the game
Zarbock, A., & Rossaint, J. (2011) · European Journal of Immunology · doi:10.1002/eji.201142196 · Cited by 14
Khongkhunthian, S., Techasatian, P., Supanchart, C., Bandhaya, P., Montreekachon, P., Thawanaphong, S., & Krisanaprakornkit, S. (2012) · Journal of Periodontology · doi:10.1902/jop.2012.120262 · Cited by 14
Umland, S. P., Wan, Y., Shah, H., Garlisi, C. G., Devito, K. E., Braunschweiger, K. I., Gheyas, F., & Mastro, R. G. D. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0220oc · Cited by 14
Elevated inflammatory gene expression in intervertebral disc tissues in mice with ADAM8 inactivated
Zhang, Y., Tian, Z., Gerard, D. A., Yao, L., Shofer, F. S., Cs‐Szabó, G., Qin, L., Pacifici, M., & Enomoto‐Iwamoto, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-81495-y · Cited by 14
AL-Ayadhi, L. Y., Abualnaja, A. A., AlZarroug, A., Alharbi, T., Alhowikan, A. M., Halepoto, D. M., & Al-Mazidi, S. H. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s408554 · Cited by 12
Identification of Key Sequence Determinants for the Inhibitory Function of the Prodomain of TACE
Gil, P. G., Galli, J. D., & Milla, M. E. (2008) · Biochemistry · doi:10.1021/bi801049v · Cited by 12
Cabañas, C., Rossi, E., Bartolomé, R. A., Doberstein, K., Altevogt, P., Casal, J. I., & Bernabéu, C. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00787-7 · Cited by 11
ADAM8 substrate specificity: Influence of pH on pre-processing and proteoglycan degradation
Hall, T., Pegg, L. E., Pauley, A. M., Fischer, H., Tomasselli, A. G., & Zack, M. D. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.09.005 · Cited by 11
Lin, W., Kang, H., Dai, Y., Niu, Y., Yang, G., Niu, J., Li, M., & Wang, F. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-03965-8 · Cited by 10
Watabe‐Uchida, M., Masuda, A., Shimada, N., Endo, M., Shimamura, K., Yasuda, K., & Sehara‐Fujisawa, A. (2004) · Developmental Dynamics · doi:10.1002/dvdy.20052 · Cited by 10
Chung, H. W., Kim, J. J., Choi, J. I., Lee, H. R., & Lim, J. (2019) · Yonsei Medical Journal · doi:10.3349/ymj.2019.60.8.713 · Cited by 9
Propofol mediates pancreatic cancer cell activity through the repression of ADAM8 via SP1
Gao, Y., Yu, Z., Wang, C., Sample, K. M., Yu, X., & Ben‐David, Y. (2021) · Oncology Reports · doi:10.3892/or.2021.8200 · Cited by 9
Roy, M. V., Lint, P. V., Laere, I. V., Wielockx, B., Wilson, C. L., López-Otı́n, C., SHAPIRO, S. D., & Libert, C. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0016 · Cited by 9
Feng, D., & Zhu, X. (2021) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672921010142 · Cited by 8
Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma
Jiang, C., Zhang, Y., Yu, H.-F., Yu, X., Zhou, S., & Tan, Y. (2012) · Tumor Biology · doi:10.1007/s13277-012-0477-1 · Cited by 8
Kang, T., Tschesche, H., & Sang, Q. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.022 · Cited by 8
Complete Downmodulation of P-Selectin Glycoprotein Ligand in Monocytes Undergoing Apoptosis
Stampfuss, J.-J., Censarek, P., Fischer, J. W., Kaber, G., Rauch, B. H., Freidel, K., Fischer, U., Schulze‐Osthoff, K., Großer, T., Grandoch, M., et al. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.166629 · Cited by 8
Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors
Cuffaro, D., Camodeca, C., Tuccinardi, T., Ciccone, L., Bartsch, J. W., Kellermann, T., Cook, L., Nuti, E., & Rossello, A. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00411 · Cited by 7
Self-citationA Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer
Mineva, N. D., Pianetti, S., Das, S. G., Srinivasan, S. S., Billiald, N. M., & Sonenshein, G. E. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16040536 · Cited by 6
He, J., & Zheng, S. (2020) · Medical Science Monitor · doi:10.12659/msm.920346 · Cited by 6
Necroptosis, ADAM proteases and intestinal (dys)function
Heib, M., Rose‐John, S., & Adam, D. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.02.001 · Cited by 7
Liu, J., Li, X., Lü, J., Xi Zhong, S. H. E. N., Li, D., Bai, L., Li, X., Yu, Z., & Li, H. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115207 · Cited by 5
Antonio, E. S., Silván, J., Sevilla‐Montero, J., González‐Sánchez, E., Muñoz‐Callejas, A., Sánchez-Abad, I., Ramos-Manzano, A., Muñoz‐Calleja, C., González‐Álvaro, I., Tomero, E., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1403104 · Cited by 5
High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma
Zhang, Y., Zha, T.-Z., Hu, B.-S., Jiang, C., Ge, Z., Zhang, K., & Tan, Y. (2012) · The Surgeon · doi:10.1016/j.surge.2012.07.002 · Cited by 5
Cuffaro, D., Scilabra, S. D., Spanò, D. P., Calligaris, M., Nuti, E., & Rossello, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823974-2.00016-4 · Cited by 6
ECM Remodeling in Angiogenesis
Grainger, S. J., & Putnam, A. J. (2012) · Studies in mechanobiology, tissue engineering and biomaterials · doi:10.1007/978-3-642-30856-7_9 · Cited by 5
The Effect of ADAM8 on the Proliferation and Apoptosis of Hepatocytes and Hepatoma Carcinoma Cells
Li, S., Hu, Z., Zhu, S., Wang, D., Han, H., & Lu, H.-J. (2015) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.21737 · Cited by 4
ADAM proteases in cytokine biology: Modulators of immune signaling, inflammation and cancer
Khattab, H., Solujic, J., & Saad, M. I. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2026.120137 · Cited by 4
Liu, H., Yu, L., Majerčiak, V., Meyer, T. J., Yi, M., Johnson, P. F., Cam, M., Lowy, D. R., & Zheng, Z. (2024) · eLife · doi:10.7554/elife.102681.3 · Cited by 3
Studies from ADAM Knockout Mice
Hoiruchi, K., & Blobel, C. (2006) · Springer eBooks · doi:10.1007/0-387-25151-0_2 · Cited by 2
RNA Aptamer Targeting of Adam8 in Cancer Growth and Metastasis
Mi, Z., Kuo, M. C., & Kuo, P. C. (2023) · Cancers · doi:10.3390/cancers15123254 · Cited by 2
ADAM and ADAMTS Proteases in Hepatic Disorders
Bolik, J., Tirnitz‐Parker, J. E. E., & Schmidt‐Arras, D. (2019) · Journal of Renal and Hepatic Disorders · doi:10.15586/jrenhep.2019.47 · Cited by 2
ADAM proteins as therapeutic targets in loosening of total hip replacement implants?
Naus, S., & Bartsch, J. W. (2005) · PubMed · Cited by 2
Self-citationLiu, H., Yu, L., Majerčiak, V., Meyer, T., Yi, M., Johnson, P. F., Cam, M., Lowy, D. R., & Zheng, Z. (2024) · eLife · doi:10.7554/elife.102681.1 · Cited by 2
Klapproth, E., Marks, J., Diaba‐Nuhoho, P., Grell, S., Leubauer, P., Kämmerer, S., Soltwedel, J. R., Rasmussen, F., Mejia, F., Moss, M. L., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70201 · Cited by 1
Romanowicz, A., Łukaszewicz‐Zając, M., & Mroczko, B. (2026) · Cancers · doi:10.3390/cancers18071127 · Cited by 1
Bartsch, J. W., Naus, S., Rittger, A., Schlomann, U., & Wildeboer, D. (2006) · Springer eBooks · doi:10.1007/0-387-25151-0_3 · Cited by 1
Self-citationSCHWARTZ, J. L., Munaretto, A. M., Bagchi, S., Crowe, D. L., & Izaguirre, G. (2015) · Journal of Cancer Therapy · doi:10.4236/jct.2015.61010 · Cited by 1
Kang, T., Newcomer, R. G., Zhao, Y., & Sang, Q. A. (2006) · Springer eBooks · doi:10.1007/0-387-25151-0_9 · Cited by 1
Variable expressions of ADAM family genes in tissues and cancer cells
Kleino, I. (2007) · Tampere University Institutional Repository (Tampere University)
ADAMs, OSTEOCLASTOGENESIS AND BONE DESTRUCTION IN THE LOOSENING OF THE TOTALLY REPLACED HIP
Ma, G. (2009) · Työväentutkimus Vuosikirja
Chapter 7 Sailing Side by Side
Jockusch, B. M., & Jockusch, H. (2008) · Comprehensive biochemistry · doi:10.1016/s0069-8032(08)00007-7
Self-citationPANNUS INVASION INTO CARTILAGE AND BONE IN RHEUMATOID ARTHRITIS
Ainola, M. (2009) · Työväentutkimus Vuosikirja
Acidosis, osteoclast formation and cathepsin K expression in the loosening of total hip prostheses
Mandelin, J. (2005) · Työväentutkimus Vuosikirja
In vitro und in vivo Charakterisierung von Endothelvorläuferzellen
Frauenschuh, J. (2006) · doi:10.14279/depositonce-1319
ADAM19structure, regulation, processing and functions
Kang, T., Newcomer, R. G., Zhao, Y., & Amy, Q.-X. (2005)
ADAM8 as a drug target in pancreatic cancer
Schlomann, U., Koller, G., Conrad, C., Ferdous, T., Golfi, P., Garcia, A. M., Höfling, S., Parsons, M., Costa, P., Soper, R., et al. (2014) · RePEc: Research Papers in Economics
Self-citationMishra, R., & Nagini, S. (2017) · Springer eBooks · doi:10.1007/978-981-10-3162-5_15
Theodorou (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180119kt
Seifert, A. (2021) · RWTH Publications (RWTH Aachen) · doi:10.18154/rwth-2021-05827
Bartsch, J. W., & Schlomann, U. (2012) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-12-382219-2.00249-0
Self-citationThe lnc-FANCI-2 intrinsically restricts RAS signaling in HPV16-infected cervical cancerPreprint
Liu, H., Yu, L., Majerčiak, V., Meyer, T., Yi, M., Johnson, P. F., Cam, M., Lowy, D. R., & Zheng, Z. (2025) · eLife · doi:10.7554/elife.102681.2
Bartsch, J. W., & Schlomann, U. (2025) · Handbook of Proteolytic Enzymes · doi:10.1016/b978-0-443-28849-4.00183-1
Self-citationMicro-environnement et cancer : rôle des adamalysines dans la progression tumorale
Dekky, B. (2018) · theses.fr (ABES) · doi:10.70675/30190222z7377z44fdzbbc4zd0a03a82efd6
Role of the protein ADAMTS12 in the progression of Chronic Liver Diseases
Azar, F. (2021) · theses.fr (ABES) · doi:10.70675/df5a3af0ze005z4d00z982fz020900d13f4e
Ki-67 promotes circulating tumor cell intravasation and metastasis in breast cancer
Zhang, Y., Zhou, J., Strittmatter, K., Zhang, Y. W., Waldmeier, M., Asawa, S., Vujanovic, M., Budinjas, S., Saini, M., Ildız, E. S., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117354
Deciphering the regulatory role of ADAM8 in the PDAC tumor microenvironment
Zandieh, K., Cook, L., Zhao, K., Nagl, C., Gao, Y., Fazio, P. D., Bartsch, D. K., Bauer, U., Meixner, M., Yildiz, D., et al. (2026) · Cellular Oncology · doi:10.1007/s13402-026-01266-7
Self-citationWolf, K. M. P., Ottenwald, L. S., Wartenberg, M., Chabria, M., & Viola Vogel, B. (2026) · Frontiers in Biophysics · doi:10.3389/frbis.2026.1781425
BindingDB Entry 50018310: Discovery of Dimeric Arylsulfonamides as Potent ADAM8 Inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q20z77hj
Metadata
- Authors
- Schlomann, U., Wildeboer, D., Webster, A., Antropova, O., Zeuschner, D., Knight, C. G., Docherty, A. J. P., Lambert, M., Skelton, L., Jockusch, H., & Bartsch, J. W.
- Affiliations
- Bielefeld University (DE)
- University of Münster (DE)
- University of Cambridge (GB)
- Corresponding author
- Bartsch, Jörg W.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 50
- Pages
- 48210-48219
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2121652791
- Cited by
- 171
- References
- 39
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 5 · 2023: 8 · 2022: 2 · 2021: 9 · 2020: 5 · 2019: 9 · 2018: 5 · 2017: 5 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 5 · 2012: 10
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Middlesex University Research Repository (Middlesex University Of London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- PUB – Publications at Bielefeld University (Bielefeld University) (submittedVersion)
- Publikationen an der Universität Bielefeld (Universität Bielefeld) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- ADAM8, ADAM metalloproteinases, disintegrin domain, autocatalytic cleavage, zinc-binding motif, cell adhesion, batimastat, tissue inhibitors of metalloproteinases, sheddases, plasma membrane localization, monocytic cells
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Catalysis, Cell Adhesion, Hydrolysis, Membrane Proteins, Metalloendopeptidases, Tumor Cells, Cultured, Antigens, CD, DNA Primers, COS Cells, Mice, ADAM Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review